Seoul, South Korea

Gwan-Sun Lee



 

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 157(Granted Patents)


Company Filing History:


Years Active: 2002-2013

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Gwan-Sun Lee in Biomedicine**

Introduction

Gwan-Sun Lee is a prolific inventor based in Seoul, South Korea, known for his significant contributions to the field of biomedicine. With an impressive portfolio of 23 patents, he has played a crucial role in advancing medical technologies and pharmaceuticals.

Latest Patents

Among his latest innovations, Gwan-Sun Lee developed a method for preparing high-purity polyethyleneglycolaldehyde derivatives, which enhances the quality and application of polyethylene glycol compounds in various medical uses. Additionally, he has patented a physiologically active polypeptide conjugate that offers a prolonged in vivo half-life. This innovative protein conjugate, which includes a physiologically active polypeptide, a non-peptidic polymer, and an immunoglobulin, is particularly beneficial for the development of polypeptide drugs. It enhances the stability and duration of these drugs in the bloodstream, while minimizing the risk of inducing an immune response.

Career Highlights

Gwan-Sun Lee has worked with notable companies in the pharmaceutical sector, including Hanmi Pharmaceutical Co., Ltd. and Hanmi Holdings Co., Ltd. His extensive experience and expertise in research and development have established him as a leading figure in his field, particularly in the development of novel drug delivery systems and therapeutic compounds.

Collaborations

Throughout his career, Gwan-Sun Lee has collaborated with fellow researchers and inventors such as Young-Kil Chang and Gha-Seung Park. These collaborations have significantly influenced his work and contributed to the advancement of innovative biomedical solutions.

Conclusion

Gwan-Sun Lee's contributions to medical science are of immense value, and his ongoing research continues to pave the way for new therapeutic options. With his remarkable track record and innovative patents, he remains a key player in the intersection of pharmaceuticals and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…